SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark Johnson who wrote (1083)8/14/1998 6:30:00 PM
From: Bob Swift  Read Replies (1) of 10280
 
Hemasure (HMSR) 2nd qtr. losses 32c a share versus 46c. Wonder why SEPR is keeping this money losing outfit and what prospect there is for it.
Question: With the world's markets going South big time and SEPR heading North ( or trying to ), who is going to win the tug of war in the next two to three months, especially in October or so when tax selling is at its peak and SEPR start to launch levalbutoral ? This tea leave is really difficult to read.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News